Literature DB >> 9497252

Genotype-phenotype relationships in ataxia-telangiectasia and variants.

S Gilad1, L Chessa, R Khosravi, P Russell, Y Galanty, M Piane, R A Gatti, T J Jorgensen, Y Shiloh, A Bar-Shira.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. A-T cells are sensitive to ionizing radiation and radiomimetic chemicals and fail to activate cell-cycle checkpoints after treatment with these agents. The responsible gene, ATM, encodes a large protein kinase with a phosphatidylinositol 3-kinase-like domain. The typical A-T phenotype is caused, in most cases, by null ATM alleles that truncate or severely destabilize the ATM protein. Rare patients with milder manifestations of the clinical or cellular characteristics of the disease have been reported and have been designated "A-T variants." A special variant form of A-T is A-TFresno, which combines a typical A-T phenotype with microcephaly and mental retardation. The possible association of these syndromes with ATM is both important for understanding their molecular basis and essential for counseling and diagnostic purposes. We quantified ATM-protein levels in six A-T variants, and we searched their ATM genes for mutations. Cell lines from these patients exhibited considerable variability in radiosensitivity while showing the typical radioresistant DNA synthesis of A-T cells. Unlike classical A-T patients, these patients exhibited 1%-17% of the normal level of ATM. The underlying ATM genotypes were either homozygous for mutations expected to produce mild phenotypes or compound heterozygotes for a mild and a severe mutation. An A-TFresno cell line was found devoid of the ATM protein and homozygous for a severe ATM mutation. We conclude that certain "A-T variant" phenotypes represent ATM mutations, including some of those without telangiectasia. Our findings extend the range of phenotypes associated with ATM mutations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9497252      PMCID: PMC1376949          DOI: 10.1086/301755

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  61 in total

1.  Variant of ataxia-telangiectasia with low-level radiosensitivity.

Authors:  M Fiorilli; A Antonelli; G Russo; M Crescenzi; M Carbonari; P Petrinelli
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

2.  Ataxia-telangiectasia: a variant with altered in vitro phenotype of fibroblast cells.

Authors:  Y Ziv; A Amiel; N G Jaspers; A I Berkel; Y Shiloh
Journal:  Mutat Res       Date:  1989-02       Impact factor: 2.433

3.  Ataxia telangiectasia in a brother and sister at older age.

Authors:  J de Jonge; C C Tijssen
Journal:  Clin Neurol Neurosurg       Date:  1988       Impact factor: 1.876

4.  Chromosomal radiation sensitivity in ataxia telangiectasia long-term lymphoblastoid cell lines.

Authors:  L G Littlefield; S P Colyer; E E Joiner; R J DuFrain; E Frome; M M Cohen
Journal:  Cytogenet Cell Genet       Date:  1981

5.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

6.  Radiosensitivity in ataxia-telangiectasia: a new explanation.

Authors:  R B Painter; B R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

Review 7.  Cellular radiosensitivity in ataxia-telangiectasia.

Authors:  J Thacker
Journal:  Int J Radiat Biol       Date:  1994-12       Impact factor: 2.694

8.  Variant forms of ataxia telangiectasia.

Authors:  A M Taylor; E Flude; B Laher; M Stacey; E McKay; J Watt; S H Green; A E Harding
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

9.  Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability.

Authors:  E Byrne; J F Hallpike; J I Manson; G R Sutherland; Y H Thong
Journal:  J Neurol Sci       Date:  1984 Nov-Dec       Impact factor: 3.181

10.  Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

Authors:  R A Gatti; I Berkel; E Boder; G Braedt; P Charmley; P Concannon; F Ersoy; T Foroud; N G Jaspers; K Lange
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

View more
  64 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Immunodeficiency associated with DNA repair defects.

Authors:  A R Gennery; A J Cant; P A Jeggo
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

Review 4.  Therapeutic potential of splice-switching oligonucleotides.

Authors:  John Bauman; Natee Jearawiriyapaisarn; Ryszard Kole
Journal:  Oligonucleotides       Date:  2009-03

5.  Exclusion/confirmation of ataxia-telangiectasia via cell-cycle testing.

Authors:  Tilman Heinrich; Carolin Prowald; Richard Friedl; Benni Gottwald; Reinhard Kalb; Kornelia Neveling; Sabine Herterich; Holger Hoehn; Detlev Schindler
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

6.  Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.

Authors:  Marie Y Davis; C Dirk Keene; Phillip D Swanson; Conor Sheehy; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-17       Impact factor: 3.181

7.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report.

Authors:  Laura Folgori; Alessia Scarselli; Giulia Angelino; Francesca Ferrari; Antonio Antoccia; Luciana Chessa; Andrea Finocchi
Journal:  Ital J Pediatr       Date:  2010-04-11       Impact factor: 2.638

Review 9.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

10.  Nonaminoglycoside compounds induce readthrough of nonsense mutations.

Authors:  Liutao Du; Robert Damoiseaux; Shareef Nahas; Kun Gao; Hailiang Hu; Julianne M Pollard; Jimena Goldstine; Michael E Jung; Susanne M Henning; Carmen Bertoni; Richard A Gatti
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.